ea0086mte5.2 | Endocrine Cancer and Late Effects | SFEBES2022
van Atteveld Jenneke
, Neggers Sebastian
In this workshop, we would like to discuss several clinical cases in the context of our recently published/collected data on bone health after childhood cancer therapy (below). Although risk factors for reduced BMD in childhood cancer survivors (CCS) had been identified, it remained unknown which survivors were at highest absolute risk of reduced BMD and might benefit from BMD assessment by DXA. In collaboration with the American SJLIFE cohort (n=2, 032), we developed...